Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1949 1
1950 1
1953 4
1955 3
1958 1
1961 3
1962 3
1963 3
1964 7
1965 19
1966 23
1967 53
1968 65
1969 98
1970 112
1971 179
1972 263
1973 280
1974 319
1975 350
1976 261
1977 248
1978 227
1979 214
1980 208
1981 206
1982 292
1983 249
1984 349
1985 425
1986 373
1987 402
1988 291
1989 376
1990 339
1991 333
1992 374
1993 354
1994 283
1995 317
1996 320
1997 298
1998 294
1999 304
2000 312
2001 284
2002 311
2003 276
2004 274
2005 263
2006 287
2007 280
2008 292
2009 315
2010 359
2011 328
2012 344
2013 328
2014 366
2015 326
2016 310
2017 301
2018 329
2019 319
2020 358
2021 293
2022 268
2023 221
2024 69

Text availability

Article attribute

Article type

Publication date

PubMed (MeSH Keyword) for id: 6253

15,651 results

Results by year

Filters applied: . Clear all
Page 1
A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1.
Zhao K, Braun M, Meyer L, Otte K, Raifer H, Helmprobst F, Möschl V, Pagenstecher A, Urban H, Ronellenfitsch MW, Steinbach JP, Pesek J, Watzer B, Nockher WA, Taudte RV, Neubauer A, Nimsky C, Bartsch JW, Rusch T. Zhao K, et al. Cells. 2024 Apr 4;13(7):632. doi: 10.3390/cells13070632. Cells. 2024. PMID: 38607071 Free PMC article.
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial.
Stelljes M, Middeke JM, Bug G, Wagner-Drouet EM, Müller LP, Schmid C, Krause SW, Bethge W, Jost E, Platzbecker U, Klein SA, Schubert J, Niederland J, Kaufmann M, Schäfer-Eckart K, Schaich M, Baldauf H, Stölzel F, Petzold C, Röllig C, Alakel N, Steffen B, Hauptrock B, Schliemann C, Sockel K, Lang F, Kriege O, Schaffrath J, Reicherts C, Berdel WE, Serve H, Ehninger G, Schmidt AH, Bornhäuser M, Mikesch JH, Schetelig J; Study Alliance Leukemia and the German Cooperative Transplant Study Group. Stelljes M, et al. Lancet Haematol. 2024 May;11(5):e324-e335. doi: 10.1016/S2352-3026(24)00065-6. Epub 2024 Apr 4. Lancet Haematol. 2024. PMID: 38583455 Free article. Clinical Trial.
15,651 results
You have reached the last available page of results. Please see the User Guide for more information.